Cabot Wealth Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Cabot Wealth Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-18,301	Closed	-$2.25M	–	143
2020 Q2	$2.25M	Sell	18,301 -1,039	-5%	-$118K	0.45%	59
2020 Q1	$1.69M	Sell	19,340 -483	-2%	-$51.1K	0.4%	63
2019 Q4	$2.07M	Sell	19,823 -792	-4%	-$88.8K	0.4%	64
2019 Q3	$2.37M	Sell	20,615 -250	-1%	-$37.9K	0.5%	62
2019 Q2	$3.6M	Buy	20,865 +5,317	+34%	+$920K	0.76%	50
2019 Q1	$2.62M	Buy	15,548 +1,078	+7%	+$160K	0.58%	59
2018 Q4	$1.41M	Buy	+14,470	New	+$1.9M	0.34%	68

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Cabot Wealth Management's GWPH Position: Q3 2020 in Review

Cabot Wealth Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2020, closing a stake of 18,301 shares — an estimated $2.25M sold.

Cabot Wealth Management first reported a position in GWPH in Q4 2018 and held it in 7 quarters. The position peaked at $3.6M in Q2 2019. 279 funds tracked by Wall St. Rank hold GWPH as of Q3 2020.

Cabot Wealth Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2020 after selling out during the quarter.
Cabot Wealth Management sold 18,301 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2020, an estimated $2.25M.
Cabot Wealth Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2018 and held it in 7 quarters.
Cabot Wealth Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $3.6M in Q2 2019.
279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2020.

Based on Cabot Wealth Management's 13F filing for Q3 2020, filed 5 Nov 2020.